| Ytd | -26.06% | |
| 1y | -7.25% |
| Open | 19.71 | Prev Close | 19.59 | Low | 19.68 | High | 19.95 | Mkt Cap | 863.78M |
| Vol | 70.44K | Avg Vol | 605.56K | EPS | 2.93 | P/E | 6.69 | Forward P/E | 5.49 |
| Beta | 0.89 | Short Ratio | 11.61 | Inst. Own | 75.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.20 | 200-d Avg | 23.18 | 1yr Est | 31.29 |
On July 2, 2026, International Medication Systems, Limited ("IMS"), a subsidiary of the Comp
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 poi
Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad
B of A Securities analyst Jason Gerberry downgrades Amphastar Pharma (NASDAQ:AMPH) from Neutral t
ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.
Amphastar Pharmaceuticals NASDAQ: AMPH is positioning itself for a broader shift from complex generi
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar
Amphastar Pharmaceuticals NASDAQ: AMPH executives told investors at the Jefferies Healthcare Confere
Barclays analyst Glen Santangelo maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH
Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view t
Wells Fargo analyst Benjamin Burnett downgrades Amphastar Pharma (NASDAQ:AMPH) from Overweight to
Amphastar Pharmaceuticals NASDAQ: AMPH executives said the company is taking steps to address rebate
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026
Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Neutral and
Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See wh
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.42 per share, missing the Za
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.42 per share which missed the analy
Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 mil
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AM
Investors interested in stocks from the Medical - Generic Drugs sector have probably already heard o
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings be
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMP
SG Americas Securities LLC purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) i
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH - Get Free Report)'s share price crossed below its two
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Gainers
Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Frida
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday